James Early

This profile gathers the share dealings of James Early in Interpace Biosciences, Inc. The record holds 4 filings, for trades running from 7 March 2018 to 29 July 2020.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 31 July 2020, reports an option exercise in Interpace Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.